HomeCompareHOLX vs CME

HOLX vs CME: Dividend Comparison 2026

HOLX yields 2.65% · CME yields 1.75%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CME wins by $4.02M in total portfolio value
10 years
HOLX
HOLX
● Live price
2.65%
Share price
$75.55
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.6K
Annual income
$314.03
Full HOLX calculator →
CME
CME
● Live price
1.75%
Share price
$297.58
Annual div
$5.20
5Y div CAGR
85.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.05M
Annual income
$3,278,693.93
Full CME calculator →

Portfolio growth — HOLX vs CME

📍 CME pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHOLXCME
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HOLX + CME cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HOLX pays
CME pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HOLX
Annual income on $10K today (after 15% tax)
$225.02/yr
After 10yr DRIP, annual income (after tax)
$266.93/yr
CME
Annual income on $10K today (after 15% tax)
$148.53/yr
After 10yr DRIP, annual income (after tax)
$2,786,889.84/yr
At 15% tax rate, CME beats the other by $2,786,622.92/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HOLX + CME for your $10,000?

HOLX: 50%CME: 50%
100% CME50/50100% HOLX
Portfolio after 10yr
$2.04M
Annual income
$1,639,503.98/yr
Blended yield
80.53%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on HOLX right now

HOLX
Analyst Ratings
18
Buy
23
Hold
1
Sell
Consensus: Hold
Price Target
$77.80
+3.0% upside vs current
Range: $76.00 — $79.00
Altman Z
4.2
Piotroski
7/9
CME
Analyst Ratings
13
Buy
17
Hold
5
Sell
Consensus: Hold
Price Target
$311.83
+4.8% upside vs current
Range: $300.00 — $340.00
Altman Z
0.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HOLX buys
0
CME buys
0
No recent congressional trades found for HOLX or CME in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHOLXCME
Forward yield2.65%1.75%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%85.4%
Portfolio after 10y$23.6K$4.05M
Annual income after 10y$314.03$3,278,693.93
Total dividends collected$2.9K$3.96M
Payment frequencyquarterlyquarterly
SectorHealthcareFinancials
Analyst consensusHoldHold
Analyst price target$77.80$311.83

Year-by-year: HOLX vs CME ($10,000, DRIP)

YearHOLX PortfolioHOLX Income/yrCME PortfolioCME Income/yrGap
1← crossover$10,965$264.73$11,024$323.97$59.00CME
2$12,004$271.27$12,414$618.83$410.00CME
3$13,121$277.55$14,491$1,207.51$1.4KCME
4$14,323$283.54$17,948$2,442.23$3.6KCME
5$15,615$289.27$24,445$5,241.07$8.8KCME
6$17,003$294.73$38,525$12,368.84$21.5KCME
7$18,493$299.93$74,998$33,775.95$56.5KCME
8$20,093$304.87$194,178$113,930.22$174.1KCME
9$21,809$309.57$718,883$511,112.41$697.1KCME
10$23,649$314.03$4,047,898$3,278,693.93$4.02MCME

HOLX vs CME: Complete Analysis 2026

HOLXHealthcare

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Full HOLX Calculator →

CMEFinancials

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.

Full CME Calculator →
📬

Get this HOLX vs CME comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HOLX vs SCHDHOLX vs JEPIHOLX vs OHOLX vs KOHOLX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.